Why Is Intellia Therapeutics Stock Sinking Monday?
Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event.
Intellia Therapeutics (NASDAQ: NTLA) paused their Phase 3 MAGNITUDE and MAGNITUDE-2 trials after a serious liver-related adverse event.
Ottawa is reportedly planning to unveil stablecoin regulations in the federal budget, echoing US reforms under the GENIUS Act as global oversight tightens. Read Full Article →
NEW YORK--(BUSINESS WIRE)--Oct 27, 2025-- Read Full Article →
The State Bank of Pakistan (SBP) on Monday decided to keep the key interest rate unchanged at 11 per cent as policymakers weighed the impact of recent floods and higher food prices on inflation. “The Monetary Policy Committee (MPC) decided to keep the policy rate unchanged at 11 per cent
WASHINGTON — Congressional Republicans came out in force Thursday in support of a Treasury Department program that helps provide loans to low-income and underserved populations that traditional financial institutions usually don’t reach. Read Full Article →